Biomarin pharmaceutical market cap
WebBioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and ... Market … WebView the latest BioMarin Pharmaceutical Inc. (BMRN) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Biomarin pharmaceutical market cap
Did you know?
WebApr 9, 2024 · BioMarin Pharmaceutical Inc. has a 12-month low of $70.73 and a 12-month high of $117.77. The company has a market cap of $18.58 billion, a PE ratio of 134.59 and a beta of 0.38. The stock has a 50 day simple moving average of $100.53 and a 200-day simple moving average of $98.13.
WebApr 13, 2024 · The business’s fifty day moving average price is $99.47 and its 200 day moving average price is $98.40. The firm has a market capitalization of $18.27 billion, a … WebBioMarin Pharmaceutical (BMRN) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund …
WebFeb 27, 2024 · BioMarin, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $537.54 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate... WebApr 13, 2024 · The company has a market cap of $18.27 billion, a price-to-earnings ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a twelve month low of …
WebApr 10, 2024 · Biomarin Pharmaceutical Inc.'s market capitalization is $18.49 B by 186.53 M shares outstanding. Is Biomarin Pharmaceutical stock a Buy, Sell or Hold? …
WebApr 12, 2024 · The stock has a market capitalization of $18.25 billion, a PE ratio of 132.22 and a beta of 0.38. BioMarin Pharmaceutical ( NASDAQ:BMRN – Get Rating) last announced its quarterly earnings... diabetes tester for smartphoneWebBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research … cindy dujic whiteWebApr 13, 2024 · BioMarin Pharmaceutical Stock Performance NASDAQ:BMRN opened at $97.96 on Thursday. The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. The... cindy duhonWebBioMarin Pharmaceutical Symbol: BMRNRank: #820Price: $111.81(-0.9128%) Market Cap: $20.7B($-189.6M)Industry: BiotechnologySector: HealthcareCountry: United StatesInsiders: 0.552%Institutions: 101.394% BioMarin Pharmaceutical Inc. Technicals 52 Week High: $114.8 52 Week Low: $70.73 50 Day MA: $99.43 200 Day MA: $88.59 cindy dutcherWebGet the latest Biomarin Pharmaceutical Inc (BMRN) real-time quote, historical performance, charts, and other financial information to help you make more informed … diabetes tertiaryWebApr 9, 2024 · BioMarin Pharmaceutical Inc. has a 12-month low of $70.73 and a 12-month high of $117.77. The company has a market cap of $18.58 billion, a PE ratio of 134.59 and a beta of 0.38. The stock... cindy dunlop lakewood coloWebApr 12, 2024 · BioMarin Pharmaceutical Inc. has a 12 month low of $70.73 and a 12 month high of $117.77. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15. The business has a 50 day simple moving average of $99.85 and a 200-day simple moving average of $98.40. diabetes test boots pharmacy